Tablet-format ultrasound changed what a single clinician can carry to a patient's side, and the Mindray TEX20 is one of the more capable entries in that category. The TEX20 is a touchscreen portable ultrasound device designed for point-of-care use across emergency, critical care, and shared-clinical environments. It pairs a compact tablet-style form factor with a probe library that covers FAST exams, lung assessments, cardiac point-of-care views, and vascular access guidance. For facilities that need real clinical capability in a form that moves without a cart, the TEX20 competes directly with other portable platforms while leaning on Mindray's familiar imaging processing stack.
Pricing on the TEX20 varies by probe configuration and software options, typically landing somewhere in the $30k–$55k band. That puts individual units near the edge of our $50,000 financing minimum, which means multi-probe or multi-unit packages clear the floor comfortably while single minimum-spec units may not. Practices buying two or three TEX20 units for different departments or coverage zones frequently structure the purchase as a single multi-unit transaction, which solves the minimum-threshold question and often gets better terms on the combined deal.
Within the Mindray family, the TEX20 typically serves as a complement to rather than a replacement for a cart system like the Mindray ME8 or a Resona platform. The TEX20 handles rapid bedside assessment; the cart handles the detailed scheduled study. Many practices finance both in a single package.